SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Trading Statement

13 Jul 2007 07:00

Flomerics Group PLC13 July 2007 Flomerics Group PLC ("Flomerics" or "the Company") Pre-Close Trading Update Flomerics Group PLC, the global supplier of specialist simulation software forelectronics and fluid flow simulation, is today providing a trading update inadvance of its interim results for the six months ended 30 June 2007. Although the first six months of the year have been challenging, the Companycontinues to make progress in integrating the Nika business, building awarenessof the Nika products in new markets and expanding its pipeline of opportunities.Through its expanded portfolio of products and additional selling capacity, theCompany is well positioned to develop its business robustly. However, asindicated in the AGM statement, building this pipeline and translating theopportunities into sales is taking longer than had been expected. This isparticularly so in the USA, where the Company has found the market weaker thanin the previous year. Flomerics continues to see a very positive reaction to the Nika product range inthose markets in which it has been introduced. It continues to build on crossselling opportunities of Nika solutions to existing Flomerics customers in theelectronics sector and is seeing benefits as a result of having broadened itsmarket beyond electronics. The directors expect the Company to report a loss in the first half of thisyear, because the costs of the investment in additional sales staff early in theyear will not be offset by increases in revenue, which are flowing through moreslowly than expected. The Company's results for the year will therefore dependeven more than usual on performance in the second half. Moreover, forecasts forthe Nika business are more difficult than for the traditional Flomericsbusiness, because it involves more sales of new products and a shorter salescycle. The Company's forecasting systems, which are well established for itstraditional business, are therefore currently showing a range of possibleoutcomes for the year. The current market expectation is at the upper end of therange and, as indicated in the AGM statement, actions are being taken to improveperformance and increase the likelihood of achieving this expectation. We willgive clearer guidance on the outlook for the year in the interim report. The Company expects to announce its interim results for the six months ended 30June 2007 in mid September 2007. Enquiries: Flomerics Group PLC:Gary Carter, Chief Executive 020 8847 3000Chris Ogle, Finance Director 020 8847 3000 Conduit PR:Christian Taylor-Wilkinson 020 7429 6666 Oriel Securities Limited (Nominated Adviser):Andrew Edwards 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Apr 202012:48 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20207:00 amRNSBusiness Update - COVID-19;Notice of Final results
27th Mar 20202:46 pmRNSDirectorate Changes
6th Mar 202012:15 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSDirector/PDMR Shareholding
14th Feb 20203:12 pmRNSHolding(s) in Company
13th Feb 20203:58 pmRNSHolding(s) in Company
13th Feb 20207:00 amRNS2019 Trading update & restructuring activities
7th Feb 20204:44 pmRNSHolding(s) in Company
6th Feb 20206:07 pmRNSHolding(s) in Company
20th Jan 20204:13 pmRNSHolding(s) in Company
15th Jan 20204:38 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSTrading Update - for the year to 31 December 2019
17th Dec 20195:43 pmRNSHolding(s) in Company
5th Dec 20194:41 pmRNSSecond Price Monitoring Extn
5th Dec 20194:35 pmRNSPrice Monitoring Extension
2nd Dec 20194:40 pmRNSSecond Price Monitoring Extn
2nd Dec 20194:35 pmRNSPrice Monitoring Extension
27th Nov 20191:51 pmRNSDirector/PDMR Shareholding
25th Nov 20194:40 pmRNSSecond Price Monitoring Extn
25th Nov 20194:35 pmRNSPrice Monitoring Extension
22nd Nov 20194:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20194:35 pmRNSPrice Monitoring Extension
30th Oct 20199:30 amRNSDirector Share Option Award
28th Oct 20197:00 amRNSDirector/PDMR Shareholding
22nd Oct 20197:00 amRNSTrading update -nine month period to 30 Sept 2019
30th Sep 20194:10 pmRNSCorrection: Director/PDMR Shareholding
30th Sep 201911:32 amRNSDirector/PDMR Shareholding
24th Sep 20197:00 amRNSHalf-Year Report - six months ended 30 June 2019
15th Aug 20191:56 pmRNSDirector/PDMR Shareholding
14th Aug 201912:08 pmRNSSecond Price Monitoring Extn
14th Aug 201912:02 pmRNSPrice Monitoring Extension
30th Jul 20197:00 amRNSIssue of Equity and Total Voting Rights (TVR)
18th Jul 201911:29 amRNSDirector/PDMR Shareholding
16th Jul 201912:07 pmRNSSecond Price Monitoring Extn
16th Jul 201912:02 pmRNSPrice Monitoring Extension
12th Jul 20197:00 amRNSGroup Trading Update & Notice of Half-Year results
13th Jun 201911:25 amRNSIssue of Equity and Total Voting Rights
5th Jun 201910:56 amRNSResults of Voting AGM - 5 June 2019 and TVR
5th Jun 20198:46 amRNS2019 Annual General Meeting Statement
16th May 20197:00 amRNSDeferred Consideration and Total Voting Rights
8th May 20191:35 pmRNSAudited Results - Notice of Annual General Meeting
7th May 201911:34 amRNSHolding(s) in Company
17th Apr 20195:21 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSPreliminary results - year ended 31 December 2018
16th Apr 20197:00 amRNSQ1 2019 Trading Update
8th Apr 20195:04 pmRNSHolding(s) in Company
26th Mar 20197:00 amRNSHolding(s) in Company
18th Mar 201911:29 amRNSDirector/PDMR Shareholding
19th Feb 20196:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.